Costa Mesa-based ICN Pharmaceuticals Inc. reported first-quarter...
- Share via
Costa Mesa-based ICN Pharmaceuticals Inc. reported first-quarter income of $4.6 million, a decline of $900,000 from the comparable period in 1987. The company cited higher interest expense, increased investments in research and development, a larger sales payroll and lower profit margins. ICN Pharmaceuticals develops, manufactures and markets pharmaceutical and biomedical products and services.
Inside the business of entertainment
The Wide Shot brings you news, analysis and insights on everything from streaming wars to production — and what it all means for the future.
You may occasionally receive promotional content from the Los Angeles Times.
